Article info

Download PDFPDF

LP-110 Development of GSTA1, CYP2C19, and CYP2B6 gene polymorphism detection methods on the response of cyclophosphamide therapy for lupus nephritis patients

Authors

  • Yen Yen Ari Indrawijaya School of Pharmacy, Institut Teknologi Bandung, Jl. Ganesha, 10 Bandung, 40132, West Java, Indonesia Department of Pharmacy, Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim Malang State Islamic University, Indonesia PubMed articlesGoogle scholar articles
  • Maria Immaculata Iwo Department of Pharmacology-Clinical Pharmacy, School of Pharmacy, Institut Teknologi Bandung, Jl. Ganesha, 10 Bandung, 40132, West Java, Indonesia PubMed articlesGoogle scholar articles
  • Aluicia Anita Artarini Laboratory of Pharmaceutical Biotechnology, School of Pharmacy, Institut Teknologi Bandung, Jl. Ganesha, 10 Bandung, 40132, West Java, Indonesia PubMed articlesGoogle scholar articles
  • Laniyati Hamijoyo Department of Internal Medicine, University of Padjajaran, Hasan Sadikin Hospital Bandung, Indonesia Immunology Study Center, Faculty of Medicine, University of Padjajaran Bandung, Indonesia PubMed articlesGoogle scholar articles

Citation

Ari Indrawijaya YY, Iwo MI, Artarini AA, et al
LP-110 Development of GSTA1, CYP2C19, and CYP2B6 gene polymorphism detection methods on the response of cyclophosphamide therapy for lupus nephritis patients

Publication history

  • First published August 6, 2023.
Online issue publication 
August 06, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.